News
21 August 2025
RNA symposium speaker spotlight - Eva Maria Novoa
With most of our RNA speakers announced, it's time to set the spotlight on another one! Get to know Eva Maria Novoa, principal investigator at Centre for Genomic Regulation (CRG) Barcelona. We're thrilled to welcome her with the talk "Decoding the epitranscriptome at single molecule resolution: towards clinical applications".
Learn more about her:
Eva Maria obtained her BSc in Biochemistry in 2007 and PhD in Biomedicine in 2012 at IRB Barcelona (Spain). Funded by EMBO and HFSP, she then relocated to the US to pursue her postdoctoral research at the Computational Biology group at MIT (USA), and then at the RNA Biology and Neuroscience laboratory at the Garvan Institute (Australia). Since 2018, Eva Maria leads the “Epitranscriptomics and RNA Dynamics” laboratory at the Center for Genomic Regulation (CRG) in Spain. Her laboratory is focused on deciphering the language of RNA modifications, and how its orchestration can regulate our cells in a space-, time- and signal-dependent manner. Her laboratory is recognized for pioneering the use and development of algorithms to study RNA modifications and other post-transcriptional regulatory mechanisms using nanopore sequencing, including the development of novel algorithms to identify RNA modifications at single molecule resolution (Begik et al., Nat Biotech 2021; Cruciani et al., Genome Biol 2025), novel approaches to multiplex native RNA sequencing runs (Pryszcz et al., Genome Res 2025), protocols to enable short RNA capturing --such as tRNA-- (Lucas et al., Nat Biotech 2023) and other non-polyadenylated molecules (Begik et al., Nat Methods 2022, Nat Protocols 2025), and her laboratory has identified and proposed the use of ‘epitranscriptomic signatures’ to predict disease (Milenkovic et al., Mol Cell 2025). Eva Maria’s work has been awarded with national and international highly prestigious grants, including the European Research Council (ERC) Starting Grant, as well as others from the NIH, AECC or MICINN, among others. Since 2024, she is also an EMBO Young Investigator (YIP).